BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 6 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,935,659 | -19.7% | 58,456 | +1.0% | 0.00% | 0.0% |
| Q2 2023 | $3,657,005 | +39.5% | 57,864 | -0.7% | 0.00% | 0.0% |
| Q1 2023 | $2,621,251 | +12.0% | 58,263 | +9.0% | 0.00% | 0.0% |
| Q4 2022 | $2,341,162 | -33.5% | 53,439 | -0.1% | 0.00% | 0.0% |
| Q3 2022 | $3,523,000 | +27.5% | 53,471 | -2.3% | 0.00% | 0.0% |
| Q2 2022 | $2,763,000 | -18.9% | 54,708 | +2.5% | 0.00% | 0.0% |
| Q1 2022 | $3,409,000 | -39.9% | 53,364 | +0.8% | 0.00% | -50.0% |
| Q4 2021 | $5,670,000 | +5.5% | 52,934 | +1.3% | 0.00% | 0.0% |
| Q3 2021 | $5,374,000 | +47.3% | 52,278 | +26.1% | 0.00% | +100.0% |
| Q2 2021 | $3,648,000 | +5.6% | 41,471 | +16.7% | 0.00% | 0.0% |
| Q1 2021 | $3,455,000 | -11.7% | 35,539 | +1.8% | 0.00% | -50.0% |
| Q4 2020 | $3,915,000 | +25.0% | 34,912 | +3.3% | 0.00% | +100.0% |
| Q3 2020 | $3,133,000 | +11.5% | 33,797 | -6.2% | 0.00% | 0.0% |
| Q2 2020 | $2,810,000 | +35.6% | 36,037 | +1.7% | 0.00% | 0.0% |
| Q1 2020 | $2,073,000 | -21.4% | 35,447 | +7.7% | 0.00% | 0.0% |
| Q4 2019 | $2,636,000 | +34.6% | 32,902 | +23.4% | 0.00% | 0.0% |
| Q3 2019 | $1,959,000 | -10.5% | 26,665 | +14.9% | 0.00% | 0.0% |
| Q2 2019 | $2,190,000 | +35.4% | 23,207 | +14.9% | 0.00% | 0.0% |
| Q1 2019 | $1,617,000 | +80.3% | 20,200 | +21.4% | 0.00% | 0.0% |
| Q4 2018 | $897,000 | -26.5% | 16,635 | +6.4% | 0.00% | 0.0% |
| Q3 2018 | $1,221,000 | +23.1% | 15,640 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $992,000 | -36.0% | 15,640 | -7.5% | 0.00% | 0.0% |
| Q1 2018 | $1,550,000 | +14.1% | 16,906 | -5.8% | 0.00% | 0.0% |
| Q4 2017 | $1,359,000 | +22.7% | 17,942 | +12.8% | 0.00% | 0.0% |
| Q3 2017 | $1,108,000 | +126.1% | 15,902 | +64.0% | 0.00% | – |
| Q2 2017 | $490,000 | +108.5% | 9,694 | +64.8% | 0.00% | – |
| Q1 2017 | $235,000 | +88.0% | 5,884 | +31.8% | 0.00% | – |
| Q4 2016 | $125,000 | +43.7% | 4,465 | +42.9% | 0.00% | – |
| Q3 2016 | $87,000 | +38.1% | 3,124 | -5.8% | 0.00% | – |
| Q2 2016 | $63,000 | – | 3,318 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,278,459 | $60,015,000 | 10.23% |
| Casdin Capital, LLC | 412,500 | $10,865,000 | 9.60% |
| Boxer Capital, LLC | 313,626 | $8,261,000 | 7.13% |
| Opaleye Management Inc. | 275,000 | $7,244,000 | 3.03% |
| RA Capital Management | 878,348 | $23,136,000 | 2.29% |
| PFM Health Sciences, LP | 1,008,232 | $26,557,000 | 0.81% |
| Perceptive Advisors | 404,404 | $10,652,000 | 0.79% |
| Partner Investment Management, L.P. | 18,052 | $475,000 | 0.78% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 680,160 | $17,915,000 | 0.60% |
| Redmile Group, LLC | 276,687 | $7,288,000 | 0.54% |